Editorial: can experimental biomarkers be useful for predicting HCC occurrence after sustained viral response in clinical settings?
LINKED CONTENT This article is linked to Moyjin et al papers. To view these articles, visit https://doi.org/10.1111/apt.16691
Gespeichert in:
| Veröffentlicht in: | Alimentary pharmacology & therapeutics 2022-01, Vol.55 (1), p.137-138 |
|---|---|
| 1. Verfasser: | |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 138 |
|---|---|
| container_issue | 1 |
| container_start_page | 137 |
| container_title | Alimentary pharmacology & therapeutics |
| container_volume | 55 |
| creator | Hosaka, Tetsuya |
| description | LINKED CONTENT
This article is linked to Moyjin et al papers. To view these articles, visit https://doi.org/10.1111/apt.16691 |
| doi_str_mv | 10.1111/apt.16716 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2610412062</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2618192228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3486-dccaf0b990b5bdfb29554f76b15735aef4b40c24b1855418403c08aa0448c71e3</originalsourceid><addsrcrecordid>eNp1kU1P3DAQhi3UChbKoX8AWeqlHAJjx3ESLgit-KiERA9wjmxnXBmydrATKOf-cbws7aEScxlp5tGj0byEfGVwxHIdq3E6YrJmcossWCmrgkMpP5EFcNkWvGHlDtlN6R4AZA18m-yUooW6qtoF-XPeuylEp4YTapSn-HvE6FboJzVQ7cJKxQeMiWqkc0I7D9SGSMeIvTOT87_o1XJJgzFzjOgNUmUnjDTNaVLOY0-fXMyiiGkMPiF1nprBeWfyMOG0NqTTL-SzVUPC_fe-R-4uzm-XV8X1zeWP5dl1YUrRyKI3RlnQbQu60r3VvK0qYWupWVWXlUIrtADDhWZNXrBGQGmgUQqEaEzNsNwj3zfeMYbHGdPUrVwyOAzKY5hTxyUDwThIntFv_6H3YY4-X7emGtZyzptMHW4oE0NKEW035t-p-NIx6NbJdDmZ7i2ZzB68G2e9wv4f-TeKDBxvgGc34MvHpu7s5-1G-QrME5kK</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2618192228</pqid></control><display><type>article</type><title>Editorial: can experimental biomarkers be useful for predicting HCC occurrence after sustained viral response in clinical settings?</title><source>MEDLINE</source><source>Wiley Online Library Free Content</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Access via Wiley Online Library</source><creator>Hosaka, Tetsuya</creator><creatorcontrib>Hosaka, Tetsuya</creatorcontrib><description>LINKED CONTENT
This article is linked to Moyjin et al papers. To view these articles, visit https://doi.org/10.1111/apt.16691</description><identifier>ISSN: 0269-2813</identifier><identifier>EISSN: 1365-2036</identifier><identifier>DOI: 10.1111/apt.16716</identifier><identifier>PMID: 34907559</identifier><language>eng</language><publisher>England: Wiley Subscription Services, Inc</publisher><subject>alpha-Fetoproteins ; Biomarkers ; Carcinoma, Hepatocellular - diagnosis ; Carcinoma, Hepatocellular - epidemiology ; Humans ; Liver Cirrhosis ; Liver Neoplasms - diagnosis ; Liver Neoplasms - epidemiology</subject><ispartof>Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (1), p.137-138</ispartof><rights>2021 John Wiley & Sons Ltd</rights><rights>Copyright © 2022 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3486-dccaf0b990b5bdfb29554f76b15735aef4b40c24b1855418403c08aa0448c71e3</cites><orcidid>0000-0003-0302-2275</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fapt.16716$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fapt.16716$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,781,785,1418,1434,27926,27927,45576,45577,46411,46835</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34907559$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Hosaka, Tetsuya</creatorcontrib><title>Editorial: can experimental biomarkers be useful for predicting HCC occurrence after sustained viral response in clinical settings?</title><title>Alimentary pharmacology & therapeutics</title><addtitle>Aliment Pharmacol Ther</addtitle><description>LINKED CONTENT
This article is linked to Moyjin et al papers. To view these articles, visit https://doi.org/10.1111/apt.16691</description><subject>alpha-Fetoproteins</subject><subject>Biomarkers</subject><subject>Carcinoma, Hepatocellular - diagnosis</subject><subject>Carcinoma, Hepatocellular - epidemiology</subject><subject>Humans</subject><subject>Liver Cirrhosis</subject><subject>Liver Neoplasms - diagnosis</subject><subject>Liver Neoplasms - epidemiology</subject><issn>0269-2813</issn><issn>1365-2036</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kU1P3DAQhi3UChbKoX8AWeqlHAJjx3ESLgit-KiERA9wjmxnXBmydrATKOf-cbws7aEScxlp5tGj0byEfGVwxHIdq3E6YrJmcossWCmrgkMpP5EFcNkWvGHlDtlN6R4AZA18m-yUooW6qtoF-XPeuylEp4YTapSn-HvE6FboJzVQ7cJKxQeMiWqkc0I7D9SGSMeIvTOT87_o1XJJgzFzjOgNUmUnjDTNaVLOY0-fXMyiiGkMPiF1nprBeWfyMOG0NqTTL-SzVUPC_fe-R-4uzm-XV8X1zeWP5dl1YUrRyKI3RlnQbQu60r3VvK0qYWupWVWXlUIrtADDhWZNXrBGQGmgUQqEaEzNsNwj3zfeMYbHGdPUrVwyOAzKY5hTxyUDwThIntFv_6H3YY4-X7emGtZyzptMHW4oE0NKEW035t-p-NIx6NbJdDmZ7i2ZzB68G2e9wv4f-TeKDBxvgGc34MvHpu7s5-1G-QrME5kK</recordid><startdate>202201</startdate><enddate>202201</enddate><creator>Hosaka, Tetsuya</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>M7N</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-0302-2275</orcidid></search><sort><creationdate>202201</creationdate><title>Editorial: can experimental biomarkers be useful for predicting HCC occurrence after sustained viral response in clinical settings?</title><author>Hosaka, Tetsuya</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3486-dccaf0b990b5bdfb29554f76b15735aef4b40c24b1855418403c08aa0448c71e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>alpha-Fetoproteins</topic><topic>Biomarkers</topic><topic>Carcinoma, Hepatocellular - diagnosis</topic><topic>Carcinoma, Hepatocellular - epidemiology</topic><topic>Humans</topic><topic>Liver Cirrhosis</topic><topic>Liver Neoplasms - diagnosis</topic><topic>Liver Neoplasms - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hosaka, Tetsuya</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Alimentary pharmacology & therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Hosaka, Tetsuya</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Editorial: can experimental biomarkers be useful for predicting HCC occurrence after sustained viral response in clinical settings?</atitle><jtitle>Alimentary pharmacology & therapeutics</jtitle><addtitle>Aliment Pharmacol Ther</addtitle><date>2022-01</date><risdate>2022</risdate><volume>55</volume><issue>1</issue><spage>137</spage><epage>138</epage><pages>137-138</pages><issn>0269-2813</issn><eissn>1365-2036</eissn><abstract>LINKED CONTENT
This article is linked to Moyjin et al papers. To view these articles, visit https://doi.org/10.1111/apt.16691</abstract><cop>England</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34907559</pmid><doi>10.1111/apt.16716</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0003-0302-2275</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-2813 |
| ispartof | Alimentary pharmacology & therapeutics, 2022-01, Vol.55 (1), p.137-138 |
| issn | 0269-2813 1365-2036 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2610412062 |
| source | MEDLINE; Wiley Online Library Free Content; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Access via Wiley Online Library |
| subjects | alpha-Fetoproteins Biomarkers Carcinoma, Hepatocellular - diagnosis Carcinoma, Hepatocellular - epidemiology Humans Liver Cirrhosis Liver Neoplasms - diagnosis Liver Neoplasms - epidemiology |
| title | Editorial: can experimental biomarkers be useful for predicting HCC occurrence after sustained viral response in clinical settings? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T08%3A17%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Editorial:%20can%20experimental%20biomarkers%20be%20useful%20for%20predicting%20HCC%20occurrence%20after%20sustained%20viral%20response%20in%20clinical%20settings?&rft.jtitle=Alimentary%20pharmacology%20&%20therapeutics&rft.au=Hosaka,%20Tetsuya&rft.date=2022-01&rft.volume=55&rft.issue=1&rft.spage=137&rft.epage=138&rft.pages=137-138&rft.issn=0269-2813&rft.eissn=1365-2036&rft_id=info:doi/10.1111/apt.16716&rft_dat=%3Cproquest_cross%3E2618192228%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2618192228&rft_id=info:pmid/34907559&rfr_iscdi=true |